Background-Cardiac-directed expression of adenylyl cyclase type VI (AC VI ) in mice results in structurally normal hearts with normal basal heart rate and function but increased responses to catecholamine stimulation. We tested the hypothesis that increased left ventricular (LV) AC VI content would increase mortality after acute myocardial infarction (MI). Methods and Results-Transgenic mice with cardiac-directed AC VI expression and their transgene-negative littermates (control) underwent coronary ligation, and survival, infarct size, and LV size and function were assessed 1 to 7 days after MI. Mice with increased AC VI expression had increased survival (control 41%, AC VI 74%; Pϭ0.004). Infarct size and myocardial apoptotic rates were similar in AC VI and control mice; however, AC VI mice had less LV dilation (PϽ0.001) and increased ejection fractions (PϽ0.03). Three days after MI, studies in isolated perfused hearts showed that basal LV ϩdP/dt was similar, but graded dobutamine infusion was associated with a more robust LV contractile response in AC VI mice (PϽ0.05). Increased LV function was associated with increases in cAMP generation (Pϭ0.0002), phospholamban phosphorylation (PϽ0.04), sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA2a) affinity for calcium (PϽ0.015), and reduced AV block (Pϭ0.04). Conclusions-In acute MI, increased cardiac AC VI content attenuates adverse LV remodeling, preserves LV contractile function, and reduces mortality. (Circulation. 2006;114:388-396.)
C ardiac-directed expression of adenylyl cyclase type VI (AC VI ) results in structurally normal hearts with normal basal heart rate and function but supranormal responses to catecholamine stimulation. 1 The use of ␤-adrenergic receptor (␤AR)-stimulating agents, which increase intracellular cAMP, may cause sustained myocardial ischemia due to increased myocardial oxygen demand or may induce ventricular arrhythmias. Whether increased cardiac content of AC VI has a deleterious effect on myocardial ischemia is unknown; however, it is reasonable to expect that increased cAMP generation and hence contractile force, with attendant exacerbation of oxygen demand/supply imbalance, would have detrimental consequences in the setting of myocardial infarction (MI) by increasing border zone injury and extending infarct size. Here, we test the hypothesis that increased left ventricular (LV) AC VI content would increase mortality after acute MI. To test this hypothesis, MI was induced by proximal left coronary ligation in transgenic mice with cardiac-directed expression of AC VI and their transgenenegative littermates. We then assessed survival, infarct size, LV size and function, apoptosis rates, cAMP production, calcium handling, and incidence of arrhythmias.
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Methods Animals
Animal use and care were in accordance with institutional and National Institutes of Health guidelines. Transgenic mice (C57BL/6) were generated with murine AC VI cDNA under direction of the ␣-myosin heavy chain promoter to produce cardiac-directed expression of AC VI . 1 Male and female AC VI transgenic mice (4Ϯ1 months old; nϭ108) and their age-matched transgene-negative littermates (control; nϭ107) were used. Gene presence was confirmed with genomic DNA purified from tail tips. Mice were housed with free access to food and water and exposed to 12-hour light/dark cycles.
Myocardial Infarction
MI was induced by permanent ligation of the left coronary artery as described previously. 2 
Survival Study
AC VI transgenic mice and their transgene-negative littermates underwent acute MI in a randomized, blinded study. This study was designed to determine the 7-day survival of mice after MI; therefore, mice that did not survive the surgical procedure were not included in the analysis. Eighty-four mice (42 AC VI ; 42 control) underwent surgery for the survival study. Sixteen mice (8 AC VI ; 8 control) died of surgical complications: 4 mice (2 AC VI ; 2 control) died before coronary ligation, 7 (4 AC VI ; 3 control) died after coronary ligation but before extubation, and 5 (2 AC VI ; 3 control) died immediately after extubation. The remaining 68 mice, consisting of 34 AC VI mice (21 males, 13 females) and 34 control mice (22 males, 12 females), were enrolled.
Infarct Size
Twenty-four hours after MI, area at risk and infarct size were assessed (nϭ7 per group) with the Evans blue and 2,3,5-triphenyltetrazolium chloride (TTC) staining technique. 3 This time point was selected to avoid differences in hypertrophy of the uninfarcted wall that might result from differences in LV AC VI expression. Measurements of the proportion of LV infarcted were therefore not confounded by differences in remodeling between groups that might occur between days 2 and 7. Methods to evaluate infarct size in mice 24 hours after coronary occlusion have been established. 4 Animals were anesthetized, intubated, and connected to a rodent ventilator. Evans Blue (1%) was injected retrogradely (via catheter) into the carotid artery to delineate the area at risk. Hearts were excised and immersed in 1% agarose and sectioned perpendicular to the long axis into 1-mm slices, which were incubated in 1.0% TTC (Sigma; St. Louis, Mo) for 5 minutes at 37°C. Each slice was weighed and photographed under a microscope. LV area, area at risk, and area of infarction for each slice were determined by planimetry with ImagePro software (Image Processing Solutions, Inc, North Reading, Mass).
In Vivo Hemodynamics
LV pressure was measured in intact mice, as described previously, 1 3 days after MI (8 AC VI , 7 control). Mice were anesthetized with ketamine (100 mg/kg IP) and xylazine (2.5 mg/kg IP). After LV pressures were recorded, bilateral vagotomy was performed. LV pressure was recorded at baseline and 45 seconds after bolus injection of isoproterenol (1, 10, and 100 pg/g in 100 L) at 5-minute intervals. Peak rates of LV pressure development (LV ϩdP/dt) and relaxation (LV ϪdP/dt) were determined after acquisition of LV pressure signals at a sampling rate of 3000 per second (Dataq DI-400, WinDaq software; Dataq Instruments, Akron, Ohio). Ten sequential beats were averaged for each measurement. Data were recorded and analyzed in a blinded manner.
Ex Vivo Hemodynamics
Ex vivo cardiac function in response to ␤AR stimulation was assessed in isolated perfused hearts, as described previously, 1 3 days after MI (nϭ6 per group). Dobutamine was delivered (1, 3 and 10 mol/L) at 5-minute intervals as LV pressure was recorded, and LV ϩdP/dt and ϪdP/dt were determined. Data were recorded and analyzed in a blinded manner.
Echocardiography
Echocardiography was performed with a 16-MHz probe (Sonos 5500, Philips, Bothell, Wash) in mice 1 before and 7 days after MI. LV ejection fraction was calculated by the area-length method, which has been validated in rodents and humans. 5
Apoptosis
Terminal dUTP nick end-labeling (TUNEL) assays were performed on LV samples with the CardioTACS In Situ Apoptosis Detection Kit (R&D Systems, Minneapolis, Minn) as described previously. 6 Seven days after MI, the heart was arrested in diastole, excised, and sliced into 3 sections perpendicular to the long axis. The slices were fixed in 3.7% formaldehyde solution for 24 hours, paraffin embed-ded, sectioned (5 m), and mounted on glass slides. Photomicrographs were obtained with a digital camera mounted on an inverted microscope. Images of 6 to 8 contiguous sections across the LV wall were obtained at the different levels (apex, mid ventricle, and base) to measure the number of TUNEL-positive cardiac myocyte nuclei in the peri-infarct border and uninfarcted remote zones, where myocyte apoptosis is reported to occur after MI. 7 Digital images were evaluated with NIH Image to count TUNEL-positive-stained nuclei and total number of nuclei in a nuclease pretreated section from the same region. Only nuclei that were clearly located in cardiac myocytes were scored. The area of each section was planimetered to calculate the average density of nuclei (nuclei per m 2 ), TUNELpositive-stained nuclei (per m 2 ), and rate of TUNEL-positive nuclei (per 10 6 nuclei).
Western Blot Analysis
LV samples were homogenized and underwent Western blot analysis as described previously. 8 -10 Antibodies to G␣s, AC V/VI , ␤ 1 AR, and ␤ 2 AR were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif); antibodies to phospholamban and sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA2a) were purchased from Affinity BioReagents (Golden, Colo); antibody to Ser16 site phosphorylated phospholamban was purchased from Upstate (Charlottesville, Va). Previous studies have shown high specificity for these antibodies. 8 -10 
LV cAMP Generation
Samples of viable LV were homogenized and cAMP levels determined before (basal) and after stimulation by 10 mol/L NKH477, a water-soluble forskolin derivative, as described previously. 10
Calcium Uptake
Samples of viable LV were homogenized, and the initial rate of ATP-dependent sarcoplasmic reticulum (SR) calcium uptake was measured by the modified Millipore (Billerica, Mass) filtration technique as described previously. 9
Telemetry
Eight AC VI transgenic mice and 8 control mice underwent telemetry implantation, as described previously. 11 Mice recovered for Ն5 days. After baseline ECG was recorded for 24 hours, MI was induced. Telemetry data were recorded with Dataquest A.R.T. acquisition software version 3.10 (Data Sciences International, Inc, St. Paul, Minn) until death or for 7 days after MI. ECG data were analyzed with ECG Auto software version 1.5.12 (EMKA Technologies, Falls Church, Va), and arrhythmic events, including premature ventricular beats and second-or third-degree AV block, during the first 24 hours after MI were visually identified (blinded to group). The agonal rhythm was assessed from the ECG data acquired 1 hour before asystole. At least 95% of the data for each mouse were adequate for analysis.
Propranolol Study
We asked whether propranolol would influence survival, LV function, or apoptosis after MI. Using normal mice (C57BL/6) with implanted telemetry units (nϭ4), we found that mean heart rate response to isoproterenol (1 mg/kg IP) was 76 bpm; propranolol (1 mg/kg IP) blocked this heart rate response, as reported previously. 11, 12 Forty-two mice (21 AC VI , 21 control) underwent MI, but animals received propranolol (1 mg/kg IP) 30 minutes before MI and every 12 hours until death or 7 days after infarction. Five mice died of surgical complications (3 AC VI , 2 control); the remaining 37 (18 AC VI , 19 control) were enrolled in the mortality study. A subset of each group underwent echocardiography (11 AC VI , 10 control) and measurement of LV apoptosis (5 AC VI , 5 control).
Statistical Analysis
Results are shown as counts or as meanϮSD. Group comparisons were made with Fisher exact test for nominal data and Mann-Whitney U tests for continuous data. Survival curves were computed by the Kaplan-Meier method and compared with the log-rank test. EC 50 values were estimated and compared with the 3-parameter sigmoidal model. Phospholamban phosphorylation content was compared with a Welch t test. The null hypothesis was rejected if PϽ0.05. Analyses were performed with SPSS for Windows (SPSS, Inc) and EC 50 calculations made with GraphPad Prism (GraphPad Software, Inc).
The authors had full access to the data and take full responsibility for their integrity. All authors have read and agree to the manuscript as written.
Results
Survival Study
Kaplan-Meier analysis revealed increased survival 7 days after MI (the primary end point of the study) in AC VI mice ( Figure 1 ). AC VI mice had a survival rate of 74% compared with 41% for the transgene-negative group (nϭ34 for each group, Pϭ0.004). All animals had anterior-wall MI at necropsy. LV rupture was found in 3 AC VI mice and 3 control mice. Figure 2 shows the delineated area at risk and infarct size in hearts stained with Evans Blue and TTC 24 hours after left coronary artery ligation. The area at risk was not different between control and AC VI mice (control 51Ϯ6%, AC VI 54Ϯ6%; nϭ7 for each group; Pϭ0.46). Infarct size was similar in both groups (control 49Ϯ7%; AC VI 51Ϯ7%; nϭ7 for each group; Pϭ0.54). The proportion of infarction related to the area at risk was also similar in both groups (control 96Ϯ2%, AC VI 96Ϯ3%; nϭ7 for each group; Pϭ0.71). Histological examination with TTC staining showed that there was no necrosis in the area of the AV node.
Infarct Size
In Vivo Hemodynamics
There were no differences in heart rate, LV ϩdP/dt, and LV ϪdP/dt between the AC VI and control groups before vagotomy (Table 1) . After vagotomy, heart rate increased to the same extent in both groups, but LV systolic pressure was higher in AC VI mice (Pϭ0.029). AC VI mice also showed increased LV ϩdP/dt (Pϭ0.021) and decreased LV ϪdP/dt (Pϭ0.029). These changes persisted when mice were stimulated with isoproterenol ( Figure 3 ). These data indicate that an increase in cardiac AC VI content increases LV contractility and relaxation 3 days after MI.
Ex Vivo Hemodynamics
To provide a means to evaluate LV function isolated from reflex activation, the influence of neurohumoral input, and anesthetic agents, hearts were isolated from AC VI and control mice 3 days after MI. Basal LV systolic pressure was higher in AC VI mice (Pϭ0.037). Basal LV ϩdP/dt was similar in both groups (control 2136Ϯ567 mm Hg/s, AC VI 2500Ϯ446 mm Hg/s; nϭ6 for each group; Pϭ0.42). Graded dobutamine infusion revealed increased LV systolic pressure ( Figure 4 ). Basal heart rate did not differ between groups (Pϭ0.132). Table 2 shows echocardiographic findings before and after MI. Before MI, there were no differences in heart rate, LV dimensions, wall thickness, and LV function between AC VI and control mice, as anticipated from our previous report. 1 Seven days after MI, heart rate and posterior wall thickness 
Echocardiography
Figure 2. A, Transverse sections of LV at the midventricular level 24 hours after MI; 1% Evans
Blue and 1% TTC. B, Area at risk was similar in control (CON) and AC VI mice. C, Infarcts were large (50Ϯ2%) and were not different between groups. Bars represent mean value; error bars denote 1 SD. nϭ7 for each group. decreased in both groups; however, LV end-diastolic diameter (PϽ0.001) and LV end-systolic diameter (PϽ0.001) were smaller in AC VI mice, which indicates reduced chamber dilation. In addition, AC VI mice showed increased LV ejection fractions (Pϭ0.034). These data suggest that cardiacdirected AC VI expression attenuates LV dilation and improves LV contractile function after MI.
Apoptosis
A Ͼ13-fold increase of TUNEL-positive nuclei was observed in the peri-infarct border zone compared with the noninfarcted remote zone for both groups (Figure 5 ). There were no differences in rates of myocardial apoptosis between control and AC VI mice in the border zone 7 days after MI (control 6719Ϯ1729 and AC VI 6495Ϯ2671 positive nuclei per 10 6 cells; nϭ7 for each group; Pϭ0.81). The apoptotic rate in the remote zone was also similar in both groups (control 472Ϯ151 and AC VI 496Ϯ156 positive nuclei per 10 6 cells; nϭ7 for each group; Pϭ0.71).
LV AC VI , G␣s, ␤ 1 AR, and ␤ 2 AR Expression
We found a 17-fold increase in AC VI protein content in LV samples from AC VI mice versus control (PϽ0.008; Figures  6A and 6B) , and AC-stimulated cAMP generation was 4.2-fold higher in viable LV samples from AC VI versus control mice 7 days after MI (Pϭ0.0002; Figure 6C ). Cardiac-directed AC VI expression did not affect basal AC activity. We found no group differences in ␤ 1 AR protein content (control 610Ϯ92 and AC VI 704Ϯ142 densitometry units; nϭ8 for each group; Pϭ0.23) or ␤ 2 AR protein content (control 129Ϯ31 and AC VI 167Ϯ67 densitometry units; nϭ8 for each group; Pϭ0.23). Similarly, we found no group difference in G␣s protein content (control 389Ϯ24 and AC VI 392Ϯ65 densitometry units; nϭ8 for each group; Pϭ0.72).
Calcium Uptake
To elucidate the mechanism by which increased cardiac AC VI protein leads to increased LV contractile function in the setting of acute MI, we assessed LV calcium signaling, a major regulator of contractile function. Western blotting analyses showed that LV SERCA2a protein content did not differ between groups (control 2176Ϯ757 and AC VI 1819Ϯ642 densitometry units; nϭ8 for each group; Pϭ0.57). Although total phospholamban was not altered by increased AC VI expression ( Figure 7A ), Ser16 phosphorylated phospholamban content was increased 2.4-fold 7 days after MI (PϽ0.04; Figures 7A and 7B) . These data suggest a role of AC VI in increasing SR calcium uptake. We then compared ATP-dependent initial SR calcium uptake rate in viable LV homogenates from both groups. The relationship between calcium uptake and calcium concentration was left-shifted in LV samples from AC VI mice ( Figure 7C ), and SERCA2a affinity for calcium was increased (EC 50 : control 3.64 mol/L, AC VI 1.14 mol/L; nϭ8 for each group; Pϭ0.0143; Figure 7D ).
Telemetry
Mean heart rate, measured with ambulatory telemetry monitors in unanesthetized animals, was similar in control and AC VI mice before MI (control 560Ϯ34 bpm, AC VI 579Ϯ52 bpm; nϭ8 for each group; Pϭ0.33), as anticipated from a previous report. 11 After coronary occlusion, we observed ST-segment elevation and subsequent formation of abnormal Q waves in each animal (Figure 8 ). Mean heart rate after MI was comparable between control and AC VI mice (control 492Ϯ84 bpm, AC VI 489Ϯ110 bpm; nϭ8 for each group; Pϭ0.88). Total number of premature ventricular complexes during the first 24 hours after MI was not different (control 2000Ϯ1714, AC VI 5056Ϯ6581; nϭ8 for each group; Pϭ0.57). The proportion of animals showing nonsustained ventricular tachycardia, a frequent occurrence after MI, was not different between groups (control 50%, AC VI 50%; PϾ0.99). AC VI mice had a reduced incidence of second-or third-degree AV block during the first 24 hours after MI (control 75%, AC VI 13%; Pϭ0.02). In this subset of animals with telemetry units, 2 of 8 AC VI transgenic mice versus 4 of 8 control mice died by the seventh day after MI; LV rupture was found in 1 AC VI and 1 control mouse. The agonal rhythm consistently was marked bradycardia with progressive highgrade AV block (Figure 8 ). Sustained ventricular tachycardia or fibrillation did not occur. Table 3 summarizes the results from the secondary study on the effects of propranolol compared with AC VI . Propranolol and AC VI had similar survival advantages (propranolol: 63% survival, nϭ19; AC VI : 74% survival, nϭ34; Pϭ0.44) and similar effects on LV ejection fraction (propranolol: 20Ϯ6%, nϭ10; AC VI : 25Ϯ6%, nϭ11; Pϭ0.09). Apoptosis rates were similar in propranolol and AC VI groups in both border and remote zones (Table 3 ).
Propranolol Study
Discussion
In acute MI, increased cardiac myocyte AC VI expression is associated with reduced mortality (56% reduction; Pϭ0.004).
The unexpected favorable effect on mortality conferred by AC VI expression led us to seek mechanisms for increased survival. We therefore measured infarct size, extent of dysfunction, degree of remodeling, apoptosis rates, cAMP generation, calcium handling, and incidence of arrhythmic events.
We asked whether increased cardiac AC VI content influenced infarct size, because LV contractile function and mortality after MI are closely linked with infarct size. There were no differences in area at risk or infarct size in a subgroup of AC VI and control mice. Infarct size averaged 50% of the LV and was not affected by increased cardiac AC VI expression ( Figure 2 ). Evaluation of LV function was performed 3 days after MI, when survival rates were comparable between the 2 groups. We measured LV function using 2 approaches: in vivo (in anesthetized, ventilated animals) and ex vivo (isolated, perfused, isovolumically contracting hearts). This was done because there are advantages and shortcomings to either approach. The apparent differences in basal LV ϩdP/dt and LV ϪdP/dt observed in the "unstimulated" state (no isoproterenol infused) may not reflect a true basal state, because surgical intervention, anesthesia, and mechanical ventilation are known to increase endogenous catecholamine release, thereby obfuscating assessment of basal heart function.
In the in vivo studies, we found increased LV ϩdP/dt and reduced LV ϪdP/dt in AC VI mice after vagotomy and after ␤AR stimulation, which indicates that increased cardiac AC VI content increases global LV contractile function and relaxation in the setting of MIs of equivalent size. Vagotomy had similar effects on heart rate in both groups, which suggests that vagal tone was similar. Thus, the differences we saw in LV dP/dt were not likely to be the result of variations in vagal tone. We previously reported that there were no differences in heart rate variability or response to atropine between AC VI transgene-positive and -negative mice in studies conducted in conscious ambulatory mice with telemetry, 11 which indicates that increased cardiac AC VI expression does not alter vagal tone.
To evaluate LV function isolated from reflex activation, neurohumoral input, and anesthesia, we assessed LV contrac-tile function in isolated perfused hearts. These studies showed that basal LV ϩdP/dt was unchanged ( Figure 4) ; however, ␤AR stimulation was associated with more robust LV systolic pressure development in AC VI mice. Increased cardiac reserve would be expected to confer a survival advantage 13 and is a likely mechanism for reduced mortality.
Echocardiography was used to assess LV size and function in vivo. There was reduced LV dilation 7 days after MI in AC VI mice, which suggests a protective effect of increased cardiac AC VI content on adverse LV remodeling after acute MI. Both infarct expansion and dilation of noninfarcted viable regions play a role in the remodeling process that occurs early after MI. Infarct size has a great impact on this deleterious process, but in the present study, infarct sizes were not different between groups. The precise mechanisms Figure 5 . A, Photomicrograph showing apoptotic nuclei (darkstained) in section of LV from the border zone of a control mouse; TUNEL staining, ϫ400. B, Apoptotic rate in the border zone was similar in control (CON) and AC VI mice 7 days after MI. C, Apoptotic rate in the remote zone was decreased compared with the border zone but was not different between groups. Bars represent mean value; error bars denote 1 SD. nϭ7 for each group. Figure 6 . AC VI expression and activity in LV. A, Abundant expression of AC VI protein was detected in LV samples from AC VI mice. B, Quantification of immunoblotting showed that AC VI expression was 17-fold higher in LV samples from AC VI mice than from transgene-negative siblings (CON; nϭ6 for each group). C, Cardiac-directed AC VI expression increased AC-stimulated cAMP production (NKH477, 10 mol/L); basal activity was unchanged (nϭ8 for each group). Bars represent mean value; error bars denote 1 SD.
Figure 7.
Cardiac-directed AC VI expression increased phospholamban (PLN) phosphorylation and calcium uptake by SR. A, Increased phosphorylated PLN content was found in LV samples from AC VI mice compared with transgene-negative littermate control (CON) mice; total PLN was unchanged. B, Quantification of immunoblotting showed that phosphorylated PLN content was 2.4-fold higher in LV samples from AC VI mice than from control mice (nϭ8 for each group). dens indicates densitometry. C, Increased LV AC VI was associated with increased SERCA2a calcium sensitivity (nϭ8 for each group). D, AC VI expression increases SERCA2a affinity for calcium (nϭ8 for each group). Data represent meanϮSD (A, B, and C), or SEE (D).
by which increased expression of AC VI attenuates adverse LV remodeling remain uncertain. Increased function in the noninfarcted viable region may contribute to preservation of global LV function and may decrease activation of the renin-angiotensin-aldosterone system and thereby reduce LV chamber dilation. Reduced LV dilation after MI would be expected to confer a survival advantage 14 and provides a second contributing mechanism for reduced mortality.
Abnormal LV calcium handling is a hallmark of heart failure. Both defective calcium uptake by SERCA2a and defective calcium release through the SR calcium release channel ryanodine receptor 2 (RyR2) occur in clinical and animal models of heart failure. 9, 15, 16 In the present study, we found that AC VI expression was associated with increased SERCA2a affinity for calcium ( Figures 7C and 7D ). This improvement of calcium uptake by AC VI was associated with increased phosphorylation of phospholamban at Ser16; protein contents of phospholamban and SERCA2a were unchanged ( Figures 7A and 7B ). Expression of a Ser16 pseudophosphorylated mutant of phospholamban in an animal model of cardiomyopathy was reported to increase calcium uptake and attenuate heart failure progression. 17 The present data provide a mechanism by which AC VI has beneficial effects on LV function and survival after MI.
Because myocardial apoptosis may contribute to the progression of LV remodeling and heart failure, we assessed myocardial apoptosis in the remote and the border zones 7 days after MI. There were no significant differences between groups in apoptotic rates in either region, which indicates that the salutary effects of increased cardiac AC VI content on LV remodeling after acute MI are not the result of reduced apoptosis. Nonetheless, it is noteworthy that increased cardiac AC VI expression does not alter myocyte apoptosis, because this result is in contrast to cardiac-directed expression of ␤ 1 AR or G␣s, which is associated with increased myocyte apoptosis and heart failure. 12, 18, 19 We previously showed that mice with cardiac-directed expression of AC VI have ambulatory heart rates similar to transgene-negative littermates. 11 In the present study, we found that increased cardiac AC VI expression, in the setting of acute MI, does not increase mean heart rate or the frequency of ventricular arrhythmias after MI. These data suggest that cardiac AC VI expression does not increase susceptibility to ventricular arrhythmias, unlike traditional sympathomimetic interventions. Nonsustained ventricular tachycardia was frequently observed early after MI, but sustained ventricular tachycardia or ventricular fibrillation was not seen. We found that the agonal rhythm consistently was bradycardia with progressive AV block. In clinical settings, MI of the large size that we induced in the present study (50% of LV) would be associated with severe heart failure. Bradycardia is commonly seen as a terminal rhythm in patients with severe heart failure. 20 In murine models of myocardial ischemia/infarction and in heart failure, very few instances of ventricular tachycardia or ventricular fibrillation have been documented, and the usual agonal rhythm is bradycardia. 21 We documented reduced mortality and reduced incidence of second-and third-degree AV block (Pϭ0.02) in mice with cardiac-directed AC VI expression. Recently, using electrophysiological approaches in transgenic mice, we found that cardiac-directed expression of AC VI facilitated AV conduction through a wide range of heart rates. 22 Increased cardiac AC VI expression, by facilitating AV conduction, would be predicted to have a protective effect on fatal bradyarrhythmias associated with MI and is likely to have played a role in the mechanism for reduced mortality that we found in the present study. AC VI and propranolol had similar salutary effects on mortality and LV remodeling in the setting of acute MI. Those who assume that AC VI gene transfer recapitulates ␤AR stimulation will think that these results are counterintuitive. However, given their unique roles as signaling moleculesone a ␤AR antagonist, the other an effector molecule for multiple G protein-coupled receptor pathways-one would not predict equal and opposite effects. Furthermore, ␤AR stimulation has effects on transcription and expression of key proteins important in cardiac function (eg, ␤ 1 AR, phospholamban, and atrial natriuretic factor) that are directionally opposite to those evoked by AC VI gene transfer. 23 
Clinical Implications
An American College of Cardiology/American Heart Association consensus panel recommends the use of ␤AR antagonists early in clinical acute MI, 24 and clinical trials indicate that the use of ␤AR antagonists in this setting reduces mortality. 25 Having established that increased cardiac content of AC VI has an unanticipated favorable effect on survival in acute MI, we performed a secondary study to determine the effects of propranolol (versus AC VI ) on mortality, LV function, and apoptosis rates in the present model. Propranolol had favorable effects on survival and LV function that were not statistically different from the effects of AC VI , and, like AC VI , propranolol did not alter apoptosis rates at this early time point after MI. The precise mechanism by which propranolol has a favorable effect on LV remodeling in clinical settings in the acute phase of MI is not known precisely, although favorable effects are associated with reduced apoptosis in longer-term studies. 26 On the basis of the present data, we would anticipate that AC VI gene transfer may have a beneficial effect on survival in acute MI in clinical settings. This effect of AC VI does not negate and may even increase the beneficial effects of ␤AR blockade.
In conclusion, increased cardiac AC VI content reduces mortality in acute MI without affecting infarct size. Three mechanisms contribute to this survival advantage: increased LV contractile responsiveness, reduced LV dilation, and reduced incidence of high-grade AV block. The molecular underpinning for favorable effects on LV function includes increased LV cAMP-generating capacity and calcium handling.
